Literature DB >> 20093419

Novel links among Wnt and TGF-beta signaling and Runx2.

Thomas L McCarthy1, Michael Centrella.   

Abstract

Osteoblasts exhibit complex Wnt-induced effects that increase T cell factor (TCF)/lymphoid enhancing factor-dependent transcription in parallel with beta-catenin stabilization and nuclear factor binding to TCF response element DNA. Here we show that Wnt-dependent gene expression increases during the early phase of osteoblast differentiation in vitro, is enhanced by prostaglandin E(2) activation of transcription factor Runx2 (runt homology domain transcription factor 2), and is specifically suppressed in Runx2 antisense-depleted osteoblasts. Moreover, Wnt pathway induction increases expression of the Runx2-sensitive gene, TGF-beta type I receptor, without increasing nuclear Runx2 levels or Runx2 binding to DNA. Rather, despite an increase in beta-catenin levels, Wnt pathway induction enhances Runx2 transcriptional potential in a beta-catenin-independent way. Runx2 functionally associates with TCF-4 that lacks a beta-catenin-binding domain and is more fully activated in response to both prostaglandin E(2) and Wnt pathway induction. Wnt pathway induction increases TGF-beta type I receptor expression, yet regulates, both positively and negatively, TGF-beta signaling. Furthermore, TGF-beta signaling enhances TCF-4 and lymphoid enhancing factor-1 mRNA expression and increases TCF-4 transcriptional activity. Therefore, we propose that cross talk between the Wnt and TGF-beta pathways, which converge on Runx2, both promotes and attenuates individual aspects of osteoblast maturation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093419      PMCID: PMC2840811          DOI: 10.1210/me.2009-0379

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  58 in total

1.  Cloning the promoter for transforming growth factor-beta type III receptor. Basal and conditional expression in fetal rat osteoblasts.

Authors:  C Ji; Y Chen; T L McCarthy; M Centrella
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

2.  CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation.

Authors:  C Ji; S Casinghino; D J Chang; Y Chen; A Javed; Y Ito; S W Hiebert; J B Lian; G S Stein; T L McCarthy; M Centrella
Journal:  J Cell Biochem       Date:  1998-06-01       Impact factor: 4.429

Review 3.  Is Wnt signalling the final common pathway leading to bone formation?

Authors:  Frances Milat; Kong Wah Ng
Journal:  Mol Cell Endocrinol       Date:  2009-06-12       Impact factor: 4.102

4.  Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor.

Authors:  C Ji; S Casinghino; T L McCarthy; M Centrella
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

5.  Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid.

Authors:  D J Chang; C Ji; K K Kim; S Casinghino; T L McCarthy; M Centrella
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

6.  Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures.

Authors:  M Centrella; V Rosen; J M Wozney; S R Casinghino; T L McCarthy
Journal:  J Cell Biochem       Date:  1997-12-15       Impact factor: 4.429

7.  Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.

Authors:  Sheri L Holmen; Troy A Giambernardi; Cassandra R Zylstra; Bree D Buckner-Berghuis; James H Resau; J Fred Hess; Vaida Glatt; Mary L Bouxsein; Minrong Ai; Matthew L Warman; Bart O Williams
Journal:  J Bone Miner Res       Date:  2004-09-13       Impact factor: 6.741

8.  Osteocalcin production in primary osteoblast cultures derived from normal and Hyp mice.

Authors:  T O Carpenter; K C Moltz; B Ellis; M Andreoli; T L McCarthy; M Centrella; D Bryan; C M Gundberg
Journal:  Endocrinology       Date:  1998-01       Impact factor: 4.736

9.  Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype.

Authors:  M Centrella; S Casinghino; J Kim; T Pham; V Rosen; J Wozney; T L McCarthy
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Human Smad3 and Smad4 are sequence-specific transcription activators.

Authors:  L Zawel; J L Dai; P Buckhaults; S Zhou; K W Kinzler; B Vogelstein; S E Kern
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

View more
  21 in total

Review 1.  TGF-β Family Signaling in Mesenchymal Differentiation.

Authors:  Ingo Grafe; Stefanie Alexander; Jonathan R Peterson; Taylor Nicholas Snider; Benjamin Levi; Brendan Lee; Yuji Mishina
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway.

Authors:  Ling Ling; Christian Dombrowski; Kin Mun Foong; Larisa M Haupt; Gary S Stein; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

3.  β-Catenin independent cross-control between the estradiol and Wnt pathways in osteoblasts.

Authors:  Thomas L McCarthy; Caleb B Kallen; Michael Centrella
Journal:  Gene       Date:  2011-02-16       Impact factor: 3.688

4.  TGFβ-1 and Wnt-3a interact to induce unique gene expression profiles in murine embryonic palate mesenchymal cells.

Authors:  Dennis R Warner; Partha Mukhopadhyay; Guy N Brock; Vasyl Pihur; M Michele Pisano; Robert M Greene
Journal:  Reprod Toxicol       Date:  2010-10-15       Impact factor: 3.143

5.  Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.

Authors:  Jun Wei; Feng Fang; Anna P Lam; Jennifer L Sargent; Emily Hamburg; Monique E Hinchcliff; Cara J Gottardi; Radhika Atit; Michael L Whitfield; John Varga
Journal:  Arthritis Rheum       Date:  2012-08

6.  Enamel matrix derivative expedites osteogenic differentiation of BMSCs via Wnt/β-catenin pathway in high glucose microenvironment.

Authors:  MaoHua Meng; Qian Xia; Ying Li; Xin Chen; QinYing Wang; JingQiao Chen; XingXing Xu; Huan Wang; JiaYu Shu; Jing Lu; Lu Cheng; ZhaoYang Ye; Bin Song; Qiang Dong
Journal:  J Bone Miner Metab       Date:  2022-03-27       Impact factor: 2.626

7.  E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation.

Authors:  Yogesh Kumar; Isha Kapoor; Kainat Khan; Gatha Thacker; Mohd Parvez Khan; Nidhi Shukla; Jitendra Kumar Kanaujiya; Sabyasachi Sanyal; Naibedya Chattopadhyay; Arun Kumar Trivedi
Journal:  J Biol Chem       Date:  2015-11-05       Impact factor: 5.157

Review 8.  Wnt and the Wnt signaling pathway in bone development and disease.

Authors:  Yiping Wang; Yi-Ping Li; Christie Paulson; Jian-Zhong Shao; Xiaoling Zhang; Mengrui Wu; Wei Chen
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

Review 9.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

10.  TCF3, a novel positive regulator of osteogenesis, plays a crucial role in miR-17 modulating the diverse effect of canonical Wnt signaling in different microenvironments.

Authors:  W Liu; Y Liu; T Guo; C Hu; H Luo; L Zhang; S Shi; T Cai; Y Ding; Y Jin
Journal:  Cell Death Dis       Date:  2013-03-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.